4,6-difluoro-N-(pyridin-2-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

5-chloro-2-[(piperidin-4-yl)methoxy]pyridine hydrochloride, 1g

4-chloro-3-nitrophenyl isocyanate, 95.0%, 25g

2-Amino-6-nitro-benzothiazol-4-ol, 1g

(2S)-1-BOC-2-METHYL-2-(METHYLAMINOMETHYL)PYRROLIDINE, 95.0%, 500mg

Ethyl 4-(3-methoxyphenyl)-4-oxobutyrate, 97.0%, 1g

(R)-Methyl 2-amino-5-guanidinopentanoate dihydrochloride, 95.0%, 5g

(R)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide, 98%, 100mg

Ethyl cis-4,7,10,13,16,19-Docosahexaenoate>97.0%(GC)100mg

(R)-1-(2,4-Difluorophenyl)ethanamine hydrochloride, 95.0%, 10g

(2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67%, 50mg

Filtration unit Rapid-Flow with PES membrane Pore size 0.45 μm, 500 ml, 500 ml, 75 mm, 12 Piece(s)

2-METHYLUNDECAN-4-ONE, 95.0%, 25g